Provided by Tiger Fintech (Singapore) Pte. Ltd.

Coherus BioSciences

0.7431
+0.01051.43%
Post-market: 0.7400-0.0031-0.42%17:59 EDT
Volume:1.78M
Turnover:1.33M
Market Cap:86.15M
PE:-0.65
High:0.7705
Open:0.7400
Low:0.7306
Close:0.7326
Loading ...

Coherus Oncology Inc. Conducted Annual Stockholders Meeting Virtually

Reuters
·
14 Jun

Coherus Biosciences completes transformation to Coherus Oncology

TIPRANKS
·
30 May

BRIEF-Coherus Completes Strategic Transformation To Coherus Oncology

Reuters
·
30 May

Coherus BioSciences Rebrands as Coherus Oncology, Emphasizing Cancer Therapeutics

Reuters
·
30 May

Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics

THOMSON REUTERS
·
30 May

Maxim Group Sticks to Its Hold Rating for Coherus Biosciences (CHRS)

TIPRANKS
·
30 May

Director Mats Wahlstrom Reports Disposal of Coherus BioSciences Inc. Common Shares

Reuters
·
29 May

Coherus BioSciences Announces Launch of Phase 1b/2 Clinical Trial for LOQTORZI and STC-15 Combination Targeting Various Cancers

Reuters
·
27 May

Coherus Announces Clinical Collaboration With Storm Therapeutics to Evaluate Stc-15 in Combination With Loqtorzi® (Toripalimab-Tpzi)

THOMSON REUTERS
·
27 May

Coherus BioSciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Coherus BioSciences Q1 Adj. EPS $(0.35) Up From $(0.48) YoY, Sales $7.60M Up From $2.31M YoY

Benzinga
·
13 May

BRIEF-Coherus BioSciences Q1 Net Income USD -56.569 Million

Reuters
·
13 May

Coherus BioSciences Reports Q1 2025: Net Loss from Continuing Operations Narrows to $47.4M, LOQTORZI Revenue at $7.3M, UDENYCA Discontinued Operations Net Revenue at $31.5M

Reuters
·
13 May

Coherus BioSciences Q1 Adj EPS From Continuing Operations $-0.35

THOMSON REUTERS
·
13 May

Coherus BioSciences Q1 Adjusted Net Income USD -40.9 Million

THOMSON REUTERS
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

Coherus BioSciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
10 May

Coherus to Report First Quarter 2025 Financial Results on May 12, 2025

GlobeNewswire
·
06 May

Coherus BioSciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
05 May

Coherus to Participate in Upcoming Investor Conferences

GlobeNewswire
·
02 May